References
  1. Gardner E. L. (2011). Addiction and brain reward and antireward pathways. Advances in psychosomatic medicine30 , 22–60. https://doi.org/10.1159/000324065
  2. Pereira, C. M., Pacagnella, R. C., Parpinelli, M. A., Andreucci, C. B., Zanardi, D. M., Souza, R., Angelini, C. R., Silveira, C., & Cecatti, J. G. (2018). Drug Use during Pregnancy and its Consequences: A Nested Case Control Study on Severe Maternal Morbidity. Uso de drogas na gestação e suas consequências: um estudo de caso-controle aninhado sobre morbidade materna grave. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia40 (9), 518–526. https://doi.org/10.1055/s-0038-1667291
  3. Forray, A., & Foster, D. (2015). Substance Use in the Perinatal Period. Current psychiatry reports17 (11), 91. https://doi.org/10.1007/s11920-015-0626-5
  4. Chagury, A. A., Tavares, K. R. C., Camargo, R. M., Martins, D. V., Marques, L. H. S., & Mahmoud, A. (2020). Pregabalin treatment in a pregnant woman with glossopharyngeal neuralgia. Brazilian journal of otorhinolaryngology86 Suppl 1 (Suppl 1), 17–19. https://doi.org/10.1016/j.bjorl.2017.01.010
  5. Wiffen, P. J., Straube, S., Derry, S., Moore, R. A., & McQuay, H. J. (2008). Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews .
  6. ‏Alsanie, W. F., Alhomrani, M., Gaber, A., Habeeballah, H., Alkhatabi, H. A., Felimban, R. I., … & Asiri, Y. A. (2022). The effects of prenatal exposure to pregabalin on the development of ventral midbrain dopaminergic neurons. Cells11 (5), 852.‏
  7. Patorno, E., Bateman, B. T., Huybrechts, K. F., MacDonald, S. C., Cohen, J. M., Desai, R. J., … & Hernandez-Diaz, S. (2017). Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology88 (21), 2020-2025.‏
  8. Winterfeld, U., Merlob, P., Baud, D., Rousson, V., Panchaud, A., Rothuizen, L. E., … & Buclin, T. (2016). Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology86 (24), 2251-2257.‏
  9. Veiby, G., Daltveit, A. K., Engelsen, B. A., & Gilhus, N. E. (2014). Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. Journal of neurology261 , 579-588.‏
  10. Chen, Z., Lin, M., Huang, Z., Zeng, L., Huang, L., Yu, D., & Zhang, L. (2019). Efficacy of chloral hydrate oral solution for sedation in pediatrics: a systematic review and meta-analysis. Drug Design, Development and Therapy , 2643-2653.
  11. Jiang, C., Xu, Y., Zhong, J., Wu, J., He, J., Xu, W., & Zhu, Y. (2022). Chloral hydrate alters brain activation induced by methamphetamine-associated cue and prevents relapse. Frontiers in Molecular Neuroscience15 , 934167.‏
  12. Smid, M. C., Metz, T. D., & Gordon, A. J. (2019). Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clinical obstetrics and gynecology62 (1), 168–184. https://doi.org/10.1097/GRF.0000000000000418
  13. Pflügner, A., Thome, U., Bernhard, M. K., Vogel, M., Bläser, A., Nickel, P., & Kiess, W. (2018). Methamphetaminkonsum während der Schwangerschaft und dessen Auswirkungen auf das Neugeborene. Klinische Pädiatrie230 (01), 31-38.‏
  14. Källén, B., & Reis, M. (2015). Use of tramadol in early pregnancy and congenital malformation risk. Reproductive Toxicology58 , 246-251.‏
  15. Sørensen, A. M. S., Noergaard, M. M., Gotfredsen, D. R., Kjærbye-Thygesen, A., Jimenez-Solem, E., Askaa, B., … & Andersen, J. T. (2022). Exposure to tramadol during early pregnancy and risk of spontaneous abortion or major congenital malformations. Obstetrics & Gynecology139 (4), 545-553.
  16. Bowie, A. C., Werler, M. M., Velez, M. P., Li, W., Camden, A., Guttmann, A., & Brogly, S. B. (2022). Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study. CMAJ194 (5), E152-E162.‏